Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna iito 600x60px
All > Germany >

News > Southern Germany

Find below news from the Southhern German Federal States of Baden-Württemberg and Bayern (Bavaria). Listed are news about this region as well as from organisations located there.

Total search results: 2184 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
High-Tech Gründerfonds Management GmbH. (2/14/19). "Press Release: Plasmion’ SICRIT Sensor Technology Convinces Investors". 2019-02-14
Medigene AG. (2/11/19). "Press Release: Medigene Appoints Axel-Sven Malkomes as CFO/CBDO". Martinsried. 2019-02-11
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
InflaRx N.V.. (2/6/19). "Press Release: InflaRx Announces Presentation of New Clinical Data with Lead Candidate IFX-1 in Hidradenitis Suppurativa". Jena. 2019-02-06
Apceth Biopharma GmbH. (1/31/19). "Press Release: Hitachi Chemical Co. Ltd. to Acquire Apceth Biopharma GmbH". Munich. 2019-01-31
MorphoSys AG. (1/31/19). "Press Release: MorphoSys Announces Settlement in Patent Lawsuit with Janssen and Genmab". Planegg. 2019-01-31
Hitachi Chemical Co., Ltd.. (1/31/19). "Press Release: Notice Regarding the Stock Acquisition of Apceth Biopharma GmbH, a Contract Manufacturer of Regenerative Medicine Products". 2019-01-31
MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. 2019-01-26
Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. 2019-01-26
BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. 2019-01-23
Kurma Partners. (1/21/19). "Press Release: Kurma Partners Sees Great Opportunities for Early-stage Biotech Investments in Germany and Launches Operations in Munich". Paris & Munich. 2019-01-21
Bruker Corporation. (1/18/19). "Press Release: Bruker Launches the G6 Leonardo for Oxygen, Nitrogen and Hydrogen (ONH) Analysis by Inert Gas Fusion". Delhi. 2019-01-18
BioMed X GmbH. (1/17/19). "Press Release: BioMed X and Boehringer Ingelheim to Investigate Early Intervention in Psychiatric Diseases". Heidelberg. 2019-01-17
MorphoSys AG. (1/17/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Expanded Clinical Development of Guselkumab (Tremfya) into Ulcerative Colitis". Planegg. 2019-01-17
Agilent Technologies Inc.. (1/16/19). "Press Release: Mala Anand to Join Agilent's Board of Directors". Santa Clara, CA. 2019-01-16
High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris". 2019-01-16
Sirion Biotech GmbH. (1/9/19). "Press Release: Sirion Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System". Munich. 2019-01-09
Immunic AG. (1/7/19). "Press Release: Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company". San Diego, CA & Planegg-Martinsried. 2019-01-07
BioMed X GmbH. (1/7/19). "Press Release: Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology". Heidelberg. 2019-01-07
Medigene AG. (1/4/19). "Press Release: Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors". Planegg. 2019-01-04
Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen. 2019-01-03
Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich. 2019-01-03
SHS Gesellschaft für Beteiligungsmanagement mbH. (12/20/18). "Press Release: SHS Invests in Swiss Life Science Company Evitria AG". Tübingen & Schlieren. 2018-12-20
Medigene AG. (12/19/18). "Press Release: Medigene Publishes Topline Interim Data from Ongoing Phase I/II Clinical Trial with DC Vaccines in AML Patients". Martinsried. 2018-12-19
High-Tech Gründerfonds Management GmbH. (12/18/18). "Press Release: High-Tech Gründerfonds and Think.Health Ventures together with Business Angels Invest 3.3 Million Euros in a Series A for the Growth of PreOmics in Martinsried, Germany". 2018-12-18
Curetis N.V.. (12/18/18). "Press Release: Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance". Vienna, Holzgerlingen & Amsterdam. 2018-12-18
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Bruker Corporation. (12/13/18). "Press Release: Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications". Billerica, MA. 2018-12-13
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Bruker Corporation. (12/10/18). "Press Release: Bruker Introduces Advanced Illumination for Next-Generation Lattice Light-Sheet Microscopy". San Diego, CA & Abbott Park, IL. 2018-12-10
LaVoieHealthScience (LHS). (12/5/18). "Press Release: Sirion Biotech Names LaVoieHealthScience as Strategic Communications Agency of Record. SIRION Biotech Plans Path for U.S. Market Expansion". Boston & Martinsried. 2018-12-05
CMS Hasche Sigle. (12/3/18). "Press Release: CMS berät Wellington und HBM als Lead Investoren der Serie D-Finanzierungsrunde der Adrenomed". München. 2018-12-03
SpinDiag GmbH. (12/3/18). "Press Release: SpinDiag Closes Second Financing Round of EUR 3.0 million (USD 3.4 million) to Complete Product Development of Its Point-of-Care Screening System for Antibiotic-resistant Bacteria". Freiburg. 2018-12-03
German Accelerator Life Sciences. (11/27/18). "Press Release: German Accelerator Life Sciences (GALS) Alumni Company SpinDiag Closes € 3M Funding Round". Freiburg & Cambridge, MA. 2018-11-27
MorphoSys AG. (11/26/18). "Press Release: MorphoSys Announces Approval of Tremfya (Guselkumab) in Japan for the Treatment of Patients with Palmoplantar Pustulosis". Planegg. 2018-11-26
InflaRx N.V.. (11/21/18). "Press Release: InflaRx N.V. Reports Third Quarter 2018 Financial & Operating Results". Jena. 2018-11-21
Apceth Biopharma GmbH. (11/16/18). "Press Release: Apceth Biopharma GmbH Manufactures DCprime’s Cell-based Cancer Vaccine for Phase II Clinical Study". Munich. 2018-11-16
MorphoSys AG. (11/15/18). "Press Release: MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210". Planegg. 2018-11-15
Medigene AG. (11/12/18). "Press Release: Medigene Reports Financial & Business Results for the First Nine Months of 2018". Planegg. 2018-11-12
Medigene AG. (11/12/18). "Press Release: Medigene Signs Exclusive License Agreement with Leiden University to Develop Novel T Cell Receptor". Martinsried. 2018-11-12
Curetis N.V.. (11/7/18). "Press Release: Curetis Raises €8.9 Million through Private Placements [Not for United States, Australia, Canada, Japan or South Africa or any other Jurisdiction where unlawful]". Amsterdam, Holzgerlingen & San Diego, CA. 2018-11-07
Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. 2018-11-06
Immunic AG. (11/5/18). "Press Release: Immunic Enters into a Global Option and License Agreement with Daiichi Sankyo". Planegg-Martinsried. 2018-11-05
MorphoSys AG. (11/5/18). "Press Release: MorphoSys AG Announces Third Quarter 2018 Results". Planegg. 2018-11-05
Curetis N.V.. (11/2/18). "Press Release: Curetis Launches Privately Placed Capital Increase to Raise up to €18.4 Million [NOT FOR THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL]". Amsterdam, Hol 2018-11-02
Omeicos Therapeutics GmbH. (11/2/18). "Press Release: Omeicos Therapeutics Closes €17m Series C Financing to Advance Lead Candidate OMT-28 Towards Pivotal Trials in Atrial Fibrillation". Berlin & Boston, MA. 2018-11-02
BioM Biotech Cluster Development GmbH. (10/30/18). "Pressemitteilung: BioM erhält Auftrag zur Projektkoordination von »DigiMed Bayern«. Bayerisches Gesundheitsministerium fördert das medizinische Digitalisierungsvorhaben mit 20 Millionen Euro über 5 Jahr 2018-10-30
Noscendo GmbH. (10/29/18). "Press Release: Noscendo Closes Financing Round for CE Certification and Market Entry Preparation of Platform Diagnostics for Bloodstream Associated Infections". Duisburg. 2018-10-29
Intrexon Corporation. (10/24/18). "Press Release: Intrexon Announces the Formation of Bioinformatics Hub in Munich. Establishing itself as Intrexon Bioinformatics Germany GmbH (IBG)". Germantown, MD. 2018-10-24
Apceth Biopharma GmbH. (10/19/18). "Press Release: Apceth Biopharma Presents Positive Data Demonstrating Efficacy of Apceth-201 in Preclinical Models of Acute GvHD". Munich. 2018-10-19
OLS Omni Life Science GmbH & Co. KG. (10/18/18). "Press Release: CERO Is a Novel 3D Cell Cultivation System". Bremen. 2018-10-18
Protagen AG. (10/18/18). "Press Release: The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Extend Their Collaboration to Investigate the Immuno-competence of Urothelial Cancer Patients Receiving Immunotherapy". 2018-10-18
Quantum Analytics. (10/16/18). "Press Release: New Distribution Agreement with Bruker AXS". Foster City, CA. 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH". Billerica, MA. 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Launches the S2 Polar High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry". Galveston, TX. 2018-10-16
Bruker Corporation. (10/11/18). "Press Release: First Global Installation of 9.4 Tesla Preclinical MRI System Combined with PET at The German Cancer Research Center (DKFZ)". Billerica, MA. 2018-10-11
Hummingbird Diagnostics GmbH. (10/9/18). "Press Release: Jörg Debatin to Chair the Supervisory Board of Hummingbird Diagnostics GmbH". Heidelberg & Boston, MA. 2018-10-09
Affimed N.V.. (10/8/18). "Press Release: Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold". Heidelberg. 2018-10-08
Probiodrug AG. (10/5/18). "Press Release: Probiodrug Reports Management Changes". Halle (Saale). 2018-10-05
Apceth Biopharma GmbH. (10/5/18). "Press Release: Apceth to Manufacture First Potential One-time Gene Therapy for Transfusion Dependent ß-Thalassemia". Munich. 2018-10-05
CeGaT GmbH. (10/1/18). "Press Release: Personalized Cancer Therapy. B. Braun and CeGaT Found Joint Venture CeCaVa". Melsungen & Tübingen. 2018-10-01
MVZ Labor Dr. Limbach & Kollegen. (9/28/18). "Pressemitteilung: Molekulargenetisches Labor erweitert das Spektrum des MVZ Labor Dr. Limbach & Kollegen". 2018-09-28
BCNP Consultants GmbH. (9/26/18). "Press Release: Over 600 Partnering Discussions at the First European Chemistry Partnering Summer Summit". Düsseldorf. 2018-09-26
InflaRx N.V.. (9/21/18). "Press Release: InflaRx N.V. Announces Appointment of Jens Holstein to Board of Directors". Jena. 2018-09-21
4SC AG. (9/20/18). "Press Release: Domatinostat Plus Chemotherapy – Overcoming Drug Resistance". Planegg-Martinsried. 2018-09-20
Plug and Play LLC. (9/20/18). "Press Release: Plug and Play Launches the First Health-focused Innovation Program in Munich – "Startup Creasphere"". Munich. 2018-09-20
Bruker Corporation. (9/14/18). "Press Release: Bruker Introduces New High Performance Preclinical PET/CT Si78 System". Seattle, WA. 2018-09-14
MorphoSys AG. (9/13/18). "Press Release: MorphoSys and Galapagos Announce Start of a Phase 1 Subcutaneous Bridging Study with MOR106". Planegg & Mechelen. 2018-09-13
RSP Systems A/S. (9/10/18). "Press Release: RSP Systems Adds EUR 3.85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10.35 Million". Odense. 2018-09-10
Definiens AG. (9/10/18). "Press Release: Definiens Embarks on Digital Pathology Collaboration with Merck's Exploratory and Clinical Development Programs". Munich. 2018-09-10
MorphoSys AG. (9/6/18). "Press Release: MorphoSys AG to Be Listed in MDAX". Planegg. 2018-09-06
Medigene AG. (9/6/18). "Press Release: Medigene Announces Inclusion in SDAX". Planegg. 2018-09-06
Probiodrug AG. (9/4/18). "Press Release: Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy". Halle (Saale). 2018-09-04
AiCuris Anti-infective Cures GmbH. (9/3/18). "Press Release: AiCuris Reports Positive Phase 1 Clinical Trial Results with Immunomodulator AIC649 in Patients with Chronic Hepatitis B". Wuppertal. 2018-09-03
Medigene AG. (8/31/18). "Press Release: Medigene Announces Change in Executive Leadership Team". Planegg. 2018-08-31
Novartis Pharma GmbH. (8/31/18). "Pressemitteilung: Novartis und das Fraunhofer IZI geben Kooperation in der CAR-T Zelltherapie für Patienten in Europa bekannt". Leipzig & Nürnberg. 2018-08-31
Roche. (8/28/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2018-08-28
Affimed N.V.. (8/27/18). "Press Release: Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets". Heidelberg. 2018-08-27
Bruker Corporation. (8/24/18). "Press Release: Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH". Billerica, MA. 2018-08-24
Medigene AG. (8/21/18). "Press Release: Medigene and Structured Immunity Announce Collaboration Aimed at Improving T Cell Receptor Development". Planegg. 2018-08-21
Stratec Biomedical AG. (8/15/18). "Press Release: Stratec Reports H1 2018 Figures and Adjusts Financial Guidance". Birkenfeld. 2018-08-15
4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. 2018-08-09
MorphoSys AG. (8/8/18). "Press Release: MorphoSys and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202". 2018-08-08
MorphoSys AG. (8/1/18). "Press Release: MorphoSys AG Reports Second Quarter 2018 Financial Results". Planegg. 2018-08-01
Qiagen N.V.. (7/30/18). "Press Release: Qiagen and Hamilton Launch New Collaboration to Improve Pre-analytical Sample Processing for QuantiFERON-TB Gold Plus". Germantown, MD & Hilden & Reno, NV. 2018-07-30
Novartis AG. (7/27/18). "Press Release: Sandoz Receives European Commission Approval for Biosimilar Hyrimoz (adalimumab)". Holzkirchen. 2018-07-27
Definiens AG. (7/26/18). "Press Release: Definiens Strengthens Digital Data and Science Strategy by Appointing Mr. Markus Schunk as Chief Operating Officer". Munich. 2018-07-26
SHS Gesellschaft für Beteiligungsmanagement mbH. (7/20/18). "Press Release: First Closing at SHS. Medical Technology Investor Raises over €90 Million for Its Fifth Fund". Tübingen. 2018-07-20
MorphoSys AG. (7/19/18). "Press Release: MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Pharma Partner". Planegg & Mechelen. 2018-07-19
Omeicos Therapeutics GmbH. (7/17/18). "Press Release: Omeicos Therapeutics Announces Compelling First-in-Human Data on Lead Compound OMT-28 and Prepares Phase 2 Trial in Atrial Fibrillation". Berlin. 2018-07-17
Apeiron Biologics AG. (7/17/18). "Press Release: Apeiron Appoints Peter Llewellyn-Davies as Chief Executive Officer". Vienna. 2018-07-17
CeGaT GmbH. (7/17/18). "Press Release: Precision Medicine – B. Braun China Enters a New Business Segment". 2018-07-17
Pepperprint GmbH. (7/12/18). "Press Release: Pepperprint Granted New US Patent. Our latest Patent Covers a Novel Method for Producing High-density Peptide Microarrays". 2018-07-12
Genmab A/S. (7/12/18). "Press Release: Genmab Enters Strategic Partnership with Immatics to Discover and Develop Next Generation Bispecific Cancer Immunotherapies". Copenhagen. 2018-07-12
MorphoSys AG. (7/10/18). "Press Release: MorphoSys Announces Its Licensee Janssen Has Initiated a Phase 2/3 Program (GALAXI) to Evaluate Tremfya (Guselkumab) in Crohn's Disease". Planegg. 2018-07-10
Biomax Informatics AG. (7/5/18). "Press Release: EUROSTARS Grants Project Funding for IMMUNOMONITOR Consortium". ’s Hertogenbosch. 2018-07-05
Boehringer Ingelheim. (6/22/18). "Press Release: Boehringer Ingelheim Bolsters Biologics Research and Development with 230 Million Euro Investment in New Development Center". Biberach. 2018-06-22
Silence Therapeutics plc. (6/21/18). "Press Release: Silence Therapeutics Strengthens Board and Leadership Team". 2018-06-21
Deinove S.A.. (6/15/18). "Press Release: Successful Capital Increase €8.5 Million [Not for United States, Canada, Australia and Japan]". Montpellier. 2018-06-15
Deinove S.A.. (6/14/18). "Press Release: Deinove Announces the Launch of a Capital Increase through an Accelerated Book Building [Not for United States, Canada, Australia and Japan]". Montpellier. 2018-06-14
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria iito 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px

» top